Back to URGN

Elmind Capital, LP → URGN

Elmind Capital, LP URGN Position History

UroGen Pharma Ltd. • Healthcare

Quarters held
4
Latest value
$20M
Q3 2026
Peak value
$20M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$2.3M
Q1 2026$4M
Q2 2026$4.4M
Q3 2026$20M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$20M491.1K——
Q2 2026$4.4M120.0K——
Q1 2026$4M220.0K——
Q4 2025$2.3M100.0K——

Other funds holding URGN

Other Elmind Capital, LP positions

COGT

COGENT BIOSCIENCES INC

$45.3M
COGT

COGENT BIOSCIENCES INC

$45.1M
SNDX

SYNDAX PHARMACEUTICALS INC

$43.3M
COGT

COGENT BIOSCIENCES INC

$41.6M
SNDX

SYNDAX PHARMACEUTICALS INC

$40.6M
SNDX

SYNDAX PHARMACEUTICALS INC

$39M
CLDX

CELLDEX THERAPEUTICS INC NEW

$36.8M
CLDX

CELLDEX THERAPEUTICS INC NEW

$36M